Indian companies need to meet U.S. drug standards if they want to continue exporting their drugs to America, the U.S. Secretary for Health and Human Services Xavier Becerra said on August 18, underlining the potential for growth in the partnership.
Speaking on the sidelines of the ongoing G-20 Health Ministers’ meeting in Gujarat’s capital, Mr. Becerra also cautioned against the unregulated proliferation of artificial intelligence across the health sector, while maintaining that it is important to harness the innovation that technology has to offer.
“Meeting the drug standards would not only help India continue its trade with the U.S. specifically, but also maintain the standards and its growth graph across the world,’’ he said, adding that India is an indispensable partner in helping the U.S. meet its pharmaceuticals needs.
